Showing results (71-80 of 151) with videos related to

Sort By:
Pageof 16
The New England Journal of Medicine|July 24, 1997
Interferon alfa-2b combined with cytarabine versus interferon alone in chronic myelogenous leukemia. French Chronic Myeloid Leukemia Study GroupF Guilhot, C Chastang, M Michallet, et al.
Experimental Hematology|August 1, 1982
Purification and cryopreservation of granulomonocytic colony forming cells (GM-CFC) from the blood of patients with chronic granulocytic leukemia (CGL) for autologous transplantationR Berthier, F Douady, A Kaufmann, et al.
Bone Marrow Transplantation|January 23, 1999
Mobilisation of healthy donors with lenograstim and transplantation of HLA-genoidentical blood progenitors in 54 patients with hematological malignancies: a pilot studyD Blaise, E Jourdan, M Michallet, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 16, 2001
Second allogeneic bone marrow transplantation in acute leukemia: results of a survey by the European Cooperative Group for Blood and Marrow TransplantationA Bosi, D Laszlo, M Labopin, et al.
Blood|December 12, 2001
Busulfan plus cyclophosphamide compared with total-body irradiation plus cyclophosphamide before marrow transplantation for myeloid leukemia: long-term follow-up of 4 randomized studiesG Socié, R A Clift, D Blaise, et al.
British Journal of Haematology|October 16, 1999
Allogeneic bone marrow transplantation in aggressive non-Hodgkin's lymphoma (excluding Burkitt and lymphoblastic lymphoma): a series of 73 patients from the SFGM database. Sociét Française de Greffe de MoelleN Dhedin, S Giraudier, P Gaulard, et al.
Bone Marrow Transplantation|April 9, 2014
Use of G-CSF to hasten neutrophil recovery after auto-SCT for AML is not associated with increased relapse incidence: a report from the Acute Leukemia Working Party of the EBMTT Czerw, M Labopin, N-C Gorin, et al.
Pathologie-Biologie|September 10, 2013
[Hematopoietic Stem Cell Transplantation using unrelated cord blood: which unit to choose? A report of the SFGM-TC]G Michel, M Detrait, V Elsermans, et al.
Bone Marrow Transplantation|September 22, 2015
Long-term outcome and prognostic factors of second allogeneic hematopoietic stem cell transplant for acute leukemia in patients with a median follow-up of ⩾10 yearsG Andreola, M Labopin, D Beelen, et al.
European Journal of Cancer (Oxford, England : 1990)|January 18, 2012
A randomised phase II study of the efficacy, safety and cost-effectiveness of pegfilgrastim and filgrastim after autologous stem cell transplant for lymphoma and myeloma (PALM study)C Sebban, A Lefranc, L Perrier, et al.
Pageof 16